The relationship between oral contraceptives and pelvic inflammatory disease: Policy implications and recommendations

Amy Yenyo, The University of Texas School of Public Health

Abstract

One of the most widely accepted noncontraceptive benefits of oral contraceptive use is the reduction in the development of pelvic inflammatory disease (PID) and its sequelae in users. While much of the research over the past forty years has found an association between oral contraceptive use and reduced rates of PID [Senanayake, 1980], more recent studies have qualified and even challenged this widely held belief. [Henry-Suchet, 1997; Ness 1997; Ness, 2001] PID, an infection in the upper genital tract causing infertility and ectopic pregnancy, affects over one million women in the United States each year, exacting an enormous toll on women's reproductive and emotional health, as well as our economy. [CDC Factsheet, 2007] This thesis examines the public health implications of pelvic inflammatory disease and the use of oral contraceptives. Sixteen original studies are reviewed and analyzed, thirteen of which found a protective benefit with oral contraceptive use against PID and three more recent studies which found no protective benefit or association between oral contraceptive use and PID. Analysis of the research findings suggests a need for additional research, provider and patient education, and an increased government role in addressing the ongoing and significant public health concerns raised by current rates of Chlamydia- and gonorrheal-PID.

Subject Area

Obstetrics|Gynecology|Public health

Recommended Citation

Yenyo, Amy, "The relationship between oral contraceptives and pelvic inflammatory disease: Policy implications and recommendations" (2008). Texas Medical Center Dissertations (via ProQuest). AAI1454386.
https://digitalcommons.library.tmc.edu/dissertations/AAI1454386

Share

COinS